20 results on '"Majgaard, O."'
Search Results
2. Impact of TNF-inhibitor treatment on radiographic joint destruction in theumatoid arthritis patients treated in clinical practice
3. TNF-inhibitors reduce radiographic joint destruction by 65 % in rheumatoid arthritis patients treated in clinical practive:Results from the nationwide Danish DANBIO registry
4. Circulating Levels of Plasma IL-6, VEGF, YKL-40, and COMP in Spondyloarthritis Patients During anti-TNFa Treatment
5. MRI-Assessment of sacroilac joint inflammation and destruction during anti-TNF-alpha therapy:Results from the Danisk investigator initiated cohort study BIOSPA
6. Changes in plasma IL-6, VEGF, YKL-40 and COMP in Spondyloarthritis Patients During Treatment with TNFa Inhibitors
7. Changes in biomarkers of cartilage and bone turnover in patients with spondyloarthritis treated with TNF-alpha inhibitors:Results from the Danisk investigator initiated cohort study BIOSPA
8. Is it possible to stop radiographic progression with conventional treatment in early rheumatoid arthritis?:2 years results from the CIMESTRA study
9. MRI Bone Oedema is the Strongest Predictor of Subsequent Radiographic Progression in Early RA. Results from a 2 Year Randomized Controlled Trial (CIMESTRA)
10. (1504/280) Intraarticular Glucocorticosteroid Therapy in Early Rheumatoid Arthritis. Influence of Joint Localization and Number of Previous Injections on the Duration of Suppression of Clinical Synovitis
11. Differentiation between early rheumatoid arthritis patients and healthy persons by conventional and dynamic contrast-enhanced magnetic resonance imaging
12. SAT0391 Does dynamic contrast-enhanced mri provide better separation of active early rheumatoid arthritis patients and healthy controls than conventional MRI?
13. ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNF inhibitors
14. Differentiation between early rheumatoid arthritis patients and healthy persons by conventional and dynamic contrast-enhanced magnetic resonance imaging.
15. Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors.
16. The ankylosing spondylitis disease activity score (ADAS) better reflects the inflammatory disease processes than BASDAI. - A comparison with biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNF-blockers
17. Is it possible to stop radiographic progression with conventional treatment in early rheumatoid arthritis?
18. Impact of drug discontinuation on radiographic progression 2 years after initiation of TNF-inhibitor treatment in clinical practice
19. Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trial.
20. Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: a study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiogenesis, and cartilage and bone turnover.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.